Evidence map›Paper›PMID 30924968›Full record

ArticleExperimental dermatology2019

Proceeding report of the third symposium on Hidradenitis Suppurativa advances (SHSA) 2018.

Claudia J Posso-De Los Rios, Akua Sarfo, Mondana Ghias, Raed Alhusayen, Iltefat Hamzavi, Michelle A Lowes, Afsaneh Alavi

Abstract readConference Proceedings
In one paragraph

Article in Experimental dermatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Claudia J Posso-De Los RiosDepartment of Medicine, Division of Dermatology, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-3710-3324
Akua SarfoDepartment of Dermatology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
Mondana GhiasAlbert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
Raed AlhusayenDivision of Dermatology, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Iltefat HamzaviDepartment of Dermatology, Henry Ford Hospital, Detroit, Michigan.
Michelle A LowesThe Rockefeller University, New York City, New York.
Afsaneh AlaviDepartment of Medicine, Division of Dermatology, University of Toronto, Toronto, Ontario, Canada.

Funding

The 3rd annual Symposium on Hidradenitis Suppurativa Advances (SHSA) meetingR13AR074881 · NIAMS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI KIRBY, JOSLYN S · 2018 to 2018
$20k
NIAMS NIH HHS R13 AR074881
6 · The paper itself

Abstract

The 3rd Annual Symposium on Hidradenitis Suppurativa Advances (SHSA) took place on 12-14 October 2018 at the Women's College Hospital in Toronto, Ontario, Canada. This symposium was a joint meeting of the Hidradenitis Suppurativa Foundation (HSF) founded in the USA and the Canadian Hidradenitis Suppurativa Foundation (CHSF). This cross-disciplinary meeting with experts from around the world was an opportunity to discuss the most recent advances in the study of hidradenitis suppurativa pathogenesis, epidemiology, classification, scoring systems, radiologic diagnosis, treatment approaches and psychologic assessment. Two special sessions this year were HS as a systemic disease and HS management guidelines. There were focused workshops on wound healing and ultrasound. There were two sessions primarily for patients and their families in the HS School programme: One workshop focused on mindfulness, and the second involved discussion among clinicians and patients about various disease aspects and the latest management. To facilitate networking between clinical and research experts and those early in their career, a mentoring breakfast was held.

Indexed as

CanadaDermatologyHidradenitis SuppurativaHumansMicroRNAsPhenotypePruritusQuality of LifeTreatment OutcomeUnited StatesWound HealingMicroRNAsclassificationdiagnosisepidemiologypathogenesistreatment

Identifiers

PMID30924968
PMCPMC6800012

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.